Hydroxychloroquine in Coronavirus Disease 2019 Patients: What Still Needs to Be Known About the Kinetics. 2020

Guillaume Martin-Blondel, and Stéphanie Ruiz, and Marlène Murris, and Stanilas Faguer, and Véronigue Duhalde, and Frédéric Eyvrard, and Jacques Izopet, and Jean-Michel Mansuy, and Yves Rolland, and Karen Delavigne, and Rosine Guimbaud, and Grégory Pugnet, and Jean-Marie Conil, and Bernard Georges, and Pierre Delobel, and Vincent Minville, and Stein Silva Sifontes, and Didier Concordet, and Peggy Gandia
Service des Maladies Infectieuses et Tropicales, Centre Hospitalo-Universitaire de Toulouse, Toulouse, France.

Different dosage regimens of hydroxychloroquine are used to manage coronavirus disease 2019 (COVID-19) patients, without information on the pharmacokinetics in this population. Blood samples (n = 101) were collected from 57 COVID-19 patients for 7 days, and concentrations were compared with simulated kinetic profiles. Hydroxychloroquine exposure is low and cannot be predicted by other populations.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006886 Hydroxychloroquine A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970) Hydroxychlorochin,Oxychlorochin,Oxychloroquine,Hydroxychloroquine Sulfate,Hydroxychloroquine Sulfate (1:1) Salt,Plaquenil
D000086402 SARS-CoV-2 A species of BETACORONAVIRUS causing atypical respiratory disease (COVID-19) in humans. The organism was first identified in 2019 in Wuhan, China. The natural host is the Chinese intermediate horseshoe bat, RHINOLOPHUS affinis. 2019 Novel Coronavirus,COVID-19 Virus,COVID19 Virus,Coronavirus Disease 2019 Virus,SARS Coronavirus 2,SARS-CoV-2 Virus,Severe Acute Respiratory Syndrome Coronavirus 2,Wuhan Coronavirus,Wuhan Seafood Market Pneumonia Virus,2019-nCoV,2019 Novel Coronaviruses,COVID 19 Virus,COVID-19 Viruses,COVID19 Viruses,Coronavirus 2, SARS,Coronavirus, 2019 Novel,Coronavirus, Wuhan,Novel Coronavirus, 2019,SARS CoV 2 Virus,SARS-CoV-2 Viruses,Virus, COVID-19,Virus, COVID19,Virus, SARS-CoV-2,Viruses, COVID19
D000093485 COVID-19 Drug Treatment The use of DRUGS to treat COVID19 or its symptoms. COVID-19 Drug Therapy,COVID19 Drug Therapy,COVID19 Drug Treatment,Coronavirus Disease 2019 Drug Treatment,Coronavirus Disease-19 Drug Treatment,COVID 19 Drug Therapy,COVID 19 Drug Treatment,COVID-19 Drug Therapies,COVID19 Drug Therapies,COVID19 Drug Treatments,Coronavirus Disease 19 Drug Treatment,Drug Therapy, COVID-19,Drug Therapy, COVID19,Therapy, COVID-19 Drug,Therapy, COVID19 Drug,Treatment, COVID-19 Drug
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral

Related Publications

Guillaume Martin-Blondel, and Stéphanie Ruiz, and Marlène Murris, and Stanilas Faguer, and Véronigue Duhalde, and Frédéric Eyvrard, and Jacques Izopet, and Jean-Michel Mansuy, and Yves Rolland, and Karen Delavigne, and Rosine Guimbaud, and Grégory Pugnet, and Jean-Marie Conil, and Bernard Georges, and Pierre Delobel, and Vincent Minville, and Stein Silva Sifontes, and Didier Concordet, and Peggy Gandia
August 2020, Cureus,
Guillaume Martin-Blondel, and Stéphanie Ruiz, and Marlène Murris, and Stanilas Faguer, and Véronigue Duhalde, and Frédéric Eyvrard, and Jacques Izopet, and Jean-Michel Mansuy, and Yves Rolland, and Karen Delavigne, and Rosine Guimbaud, and Grégory Pugnet, and Jean-Marie Conil, and Bernard Georges, and Pierre Delobel, and Vincent Minville, and Stein Silva Sifontes, and Didier Concordet, and Peggy Gandia
June 2000, BMJ (Clinical research ed.),
Guillaume Martin-Blondel, and Stéphanie Ruiz, and Marlène Murris, and Stanilas Faguer, and Véronigue Duhalde, and Frédéric Eyvrard, and Jacques Izopet, and Jean-Michel Mansuy, and Yves Rolland, and Karen Delavigne, and Rosine Guimbaud, and Grégory Pugnet, and Jean-Marie Conil, and Bernard Georges, and Pierre Delobel, and Vincent Minville, and Stein Silva Sifontes, and Didier Concordet, and Peggy Gandia
June 2020, The journal of the Royal College of Physicians of Edinburgh,
Guillaume Martin-Blondel, and Stéphanie Ruiz, and Marlène Murris, and Stanilas Faguer, and Véronigue Duhalde, and Frédéric Eyvrard, and Jacques Izopet, and Jean-Michel Mansuy, and Yves Rolland, and Karen Delavigne, and Rosine Guimbaud, and Grégory Pugnet, and Jean-Marie Conil, and Bernard Georges, and Pierre Delobel, and Vincent Minville, and Stein Silva Sifontes, and Didier Concordet, and Peggy Gandia
November 2022, Food chemistry,
Guillaume Martin-Blondel, and Stéphanie Ruiz, and Marlène Murris, and Stanilas Faguer, and Véronigue Duhalde, and Frédéric Eyvrard, and Jacques Izopet, and Jean-Michel Mansuy, and Yves Rolland, and Karen Delavigne, and Rosine Guimbaud, and Grégory Pugnet, and Jean-Marie Conil, and Bernard Georges, and Pierre Delobel, and Vincent Minville, and Stein Silva Sifontes, and Didier Concordet, and Peggy Gandia
July 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
Guillaume Martin-Blondel, and Stéphanie Ruiz, and Marlène Murris, and Stanilas Faguer, and Véronigue Duhalde, and Frédéric Eyvrard, and Jacques Izopet, and Jean-Michel Mansuy, and Yves Rolland, and Karen Delavigne, and Rosine Guimbaud, and Grégory Pugnet, and Jean-Marie Conil, and Bernard Georges, and Pierre Delobel, and Vincent Minville, and Stein Silva Sifontes, and Didier Concordet, and Peggy Gandia
March 2020, Clinical nephrology,
Guillaume Martin-Blondel, and Stéphanie Ruiz, and Marlène Murris, and Stanilas Faguer, and Véronigue Duhalde, and Frédéric Eyvrard, and Jacques Izopet, and Jean-Michel Mansuy, and Yves Rolland, and Karen Delavigne, and Rosine Guimbaud, and Grégory Pugnet, and Jean-Marie Conil, and Bernard Georges, and Pierre Delobel, and Vincent Minville, and Stein Silva Sifontes, and Didier Concordet, and Peggy Gandia
September 2020, JAMA cardiology,
Guillaume Martin-Blondel, and Stéphanie Ruiz, and Marlène Murris, and Stanilas Faguer, and Véronigue Duhalde, and Frédéric Eyvrard, and Jacques Izopet, and Jean-Michel Mansuy, and Yves Rolland, and Karen Delavigne, and Rosine Guimbaud, and Grégory Pugnet, and Jean-Marie Conil, and Bernard Georges, and Pierre Delobel, and Vincent Minville, and Stein Silva Sifontes, and Didier Concordet, and Peggy Gandia
April 2020, Kardiologia polska,
Guillaume Martin-Blondel, and Stéphanie Ruiz, and Marlène Murris, and Stanilas Faguer, and Véronigue Duhalde, and Frédéric Eyvrard, and Jacques Izopet, and Jean-Michel Mansuy, and Yves Rolland, and Karen Delavigne, and Rosine Guimbaud, and Grégory Pugnet, and Jean-Marie Conil, and Bernard Georges, and Pierre Delobel, and Vincent Minville, and Stein Silva Sifontes, and Didier Concordet, and Peggy Gandia
December 2023, Progress in neuro-psychopharmacology & biological psychiatry,
Guillaume Martin-Blondel, and Stéphanie Ruiz, and Marlène Murris, and Stanilas Faguer, and Véronigue Duhalde, and Frédéric Eyvrard, and Jacques Izopet, and Jean-Michel Mansuy, and Yves Rolland, and Karen Delavigne, and Rosine Guimbaud, and Grégory Pugnet, and Jean-Marie Conil, and Bernard Georges, and Pierre Delobel, and Vincent Minville, and Stein Silva Sifontes, and Didier Concordet, and Peggy Gandia
April 2021, Infection,
Copied contents to your clipboard!